Literature DB >> 2836620

Structure and complete nucleotide sequence of the Marek's disease herpesvirus gp57-65 gene.

P M Coussens1, L F Velicer.   

Abstract

The gene encoding the precursor polypeptide of the Marek's disease herpesvirus (MDHV) secretory glycoprotein gp57-65 (formerly identified as A antigen) has been sequenced. Previous results had localized the gene to a 4.6-kilobase (kb) segment of the BamHI B fragment in the unique long region of the MDHV genome. S1 nuclease protection experiments were used to more precisely locate the 5' initiation and approximate 3' termination points of the approximately 1.8-kb MDHV gp57-65 mRNA within this segment. These results indicated that the entire MDHV gp57-65 coding sequence is contained within a 2.35-kb PvuII-EcoRI fragment, with the direction of transcription from PvuII to EcoRI (5' to 3'). Nucleotide sequence analysis of this region revealed a single open reading frame of 1,515 base pairs. The MDHV gp57-65 coding sequence has an overall guanosine-plus-cytosine content of 41%. Translation of the single open reading frame would produce a polypeptide of 505 amino acids, with a calculated molecular weight of 56,805. The putative gp57-65 precursor polypeptide contains features common to many glycoproteins. These include a hydrophobic amino-terminal region (amino acids 1 to 27) that may function as a signal peptide and nine potential N-linked glycosylation sites (Asn-X-Ser/Thr). These two features, predicted from nucleotide sequence data, are consistent with the published data showing that gp57-65 has a signal peptide and N-linked glycosylation (R. J. Isfort, R. A. Stringer, H.-J. Kung, and L. F. Velicer, J. Virol. 57:464-474, 1986). The predicted sequence indicates that overall the polypeptide is relatively hydrophobic, with a possible 18-residue carboxyl-terminal membrane anchor sequence. This sequence appears to be less prominent than those commonly found in integral membrane glycoproteins. The lack of a strong hydrophobic anchor sequence may help to explain the predominantly secretory nature of MDHV gp57-65.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2836620      PMCID: PMC253394          DOI: 10.1128/JVI.62.7.2373-2379.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

Review 1.  The structure and isomerization of herpes simplex virus genomes.

Authors:  B Roizman
Journal:  Cell       Date:  1979-03       Impact factor: 41.582

2.  Identification of the gene encoding Marek's disease herpesvirus A antigen.

Authors:  R J Isfort; H J Kung; L F Velicer
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

3.  Synthesis, processing, and secretion of the Marek's disease herpesvirus A antigen glycoprotein.

Authors:  R J Isfort; R A Stringer; H J Kung; L F Velicer
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

4.  Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus.

Authors:  R L Witter; K Nazerian; H G Purchase; G H Burgoyne
Journal:  Am J Vet Res       Date:  1970-03       Impact factor: 1.156

5.  Marek's disease herpesviruses. IV. Molecular characterization of Marek's disease herpesvirus A antigen.

Authors:  C Glaubiger; K Nazerian; L F Velicer
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

6.  Serological relationship between a pathogenic strain of Marek's disease virus, its attenuated derivative and herpes virus of turkeys.

Authors:  L J Ross; O Basarab; D J Walker; B Whitby
Journal:  J Gen Virol       Date:  1975-07       Impact factor: 3.891

7.  Genetic resistance to Marek's disease. Delineation of the response of genetically resistant chickens to Marek's disease virus infection.

Authors:  J M Sharma; H A Stone
Journal:  Avian Dis       Date:  1972 Jul-Sep       Impact factor: 1.577

8.  Size and composition of Marek's disease virus deoxyribonucleic acid.

Authors:  L F Lee; E D Kieff; S L Bachenheimer; B Roizman; P G Spear; B R Burmester; K Nazerian
Journal:  J Virol       Date:  1971-03       Impact factor: 5.103

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Most virus-specific polypeptides in cells productively infected with Marek's disease virus or herpesvirus of turkeys possess cross-reactive determinants.

Authors:  K Ikuta; S Ueda; S Kato; K Hirai
Journal:  J Gen Virol       Date:  1983-04       Impact factor: 3.891

View more
  14 in total

1.  The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus.

Authors:  L F Lee; P Wu; D Sui; D Ren; J Kamil; H J Kung; R L Witter
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  Comparative sequence analysis of a highly oncogenic but horizontal spread-defective clone of Marek's disease virus.

Authors:  Stephen J Spatz; Yuguang Zhao; Lawrence Petherbridge; Lorraine P Smith; Susan J Baigent; Venugopal Nair
Journal:  Virus Genes       Date:  2007-08-25       Impact factor: 2.332

3.  Synthesis and processing of the Marek's disease herpesvirus B antigen glycoprotein complex.

Authors:  I Sithole; L F Lee; L F Velicer
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

4.  Monospecific antibodies to Marek's disease virus antigen B dimer (200 kDa) and monomer (130 and 60 kDa) glycoproteins neutralize virus infectivity and detect the antigen B proteins in infected cell membranes.

Authors:  I Davidson; Y Becker; M Malkinson
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

5.  Open reading frames in a 4556 nucleotide sequence within MDV-1 BamHI-D DNA fragment: evidence for splicing of mRNA from a new viral glycoprotein gene.

Authors:  Y Becker; Y Asher; E Tabor; I Davidson; M Malkinson
Journal:  Virus Genes       Date:  1994-01       Impact factor: 2.332

6.  Marek's disease virus gene clones encoding virus-specific phosphorylated polypeptides and serological characterization of fusion proteins.

Authors:  Z Z Cui; D Yan; L F Lee
Journal:  Virus Genes       Date:  1990-04       Impact factor: 2.332

7.  Characterization of the gene encoding herpesvirus of turkeys gp57-65: comparison to Marek's disease virus gp57-65 and herpes simplex virus glycoprotein C.

Authors:  P M Coussens; M R Wilson; H Camp; H Roehl; R J Isfort; L F Velicer
Journal:  Virus Genes       Date:  1990-04       Impact factor: 2.332

8.  Comparison of the sequence of the secretory glycoprotein A (gA) gene in Md5 and BC-1 strains of Marek's disease virus type 1.

Authors:  T Ihara; A Kato; S Ueda; A Ishihama; K Hirai
Journal:  Virus Genes       Date:  1989-11       Impact factor: 2.332

9.  Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells.

Authors:  Z Z Cui; L F Lee; J L Liu; H J Kung
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

10.  Expression of a novel Marek's disease virus type 1 (MDV1)-specific protein p40 in insect cells by a baculovirus vector and in chick embryo fibroblasts infected with MDV1.

Authors:  T Urakawa; M Sakaguchi; M Yamamoto; G S Zhu; K Hirai
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.